Comparison of the real-world safety of two different long-acting methylphenidate formulations (Medikinet^® MR and Concerta^®) – a Danish nationwide register-based cohort study

Categoria dell'articolo: Research Article

Pubblicato online: 16 nov 2024

Pagine: 84 - 91

DOI: https://doi.org/10.2478/sjcapp-2024-0009

Parole chiave

Methylphenidate, real-world safety, adverse events, attention-deficit hyperactivity disorder, register study

© 2024 Jakob Ørnberg et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.